Downregulation of miR-221-3p and upregulation of its target gene PARP1 are prognostic biomarkers for triple negative breast cancer patients and associated with poor prognosis-Reference-Cited by-同舟云学术

Downregulation of miR-221-3p and upregulation of its target gene PARP1 are prognostic biomarkers for triple negative breast cancer patients and associated with poor prognosis

Published:2017-10-06 Issue:65 Volume:8 Page:108712-108725
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Deng Ling¹,Lei Qianqian¹²,Wang Yu¹,Wang Zhu¹,Xie Guiqin¹,Zhong Xiaorong¹,Wang Yanping¹,Chen Nianyong³,Qiu Yan⁴,Pu Tianjie⁴,Bu Hong⁴,Zheng Hong¹³

Affiliation:

1. Laboratory of Molecular Diagnosis of Cancer, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, National Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu, China

2. Department of Radiation Oncology, Chongqing Cancer Institute & Hospital & Cancer Center, Chongqing, China

3. Cancer center, West China Hospital, Sichuan University, Chengdu, China

4. Department of Pathology, West China Hospital, Sichuan University, Chengdu, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Poly (Adp-Ribose) Polymerase-1 (PARP-1) Is a Good Prognostic Marker for Pancreatic/Periampullary Cancers;Pancreas;2024-03-27

2. Value of the NF-κB signalling pathway and the DNA repair gene PARP1 in predicting distant metastasis after breast cancer surgery;Scientific Reports;2024-02-22

3. Correlation of mir-221-3p differential expression with clinical characteristics of gastric cancer patients;Molecular Biology Reports;2024-01-04

4. Prospectives of mirna gene signaling pathway in triple-negative breast cancer;Pathology - Research and Practice;2023-08

5. A group of three miRNAs can act as candidate circulating biomarkers in liquid biopsies from melanoma patients;Frontiers in Medicine;2023-06-14